Effect of Nigella sativa (black seed) supplementation on glycemic control: A systematic review and meta-analysis of clinical trials

Phytother Res. 2019 May;33(5):1341-1352. doi: 10.1002/ptr.6337. Epub 2019 Mar 14.

Abstract

This study was aimed to quantify the antihyperglycemic effect of Nigella sativa (N. sativa). An in-depth search to identify clinical trials investigating the impact of N. sativa on glycemic indices via MEDLINE, EMBASE, Scopus, Web of Science, Cochrane Library, and Google scholar databases were performed up to November 2018. We used a random effects model to estimate pooled effect size of fasting plasma glucose (FPG), postprandial blood glucose (PPBG), and hemoglobin A1c (HbA1c). A total of 17 randomized controlled trials investigating the effects of N. sativa on FPG, PPBG, and HbA1c were included. Meta-analysis suggested a significant association between N. sativa supplementation and reduction in FPG (weighted mean difference [WMD]: -9.93 mg/dl, 95% CI [-13.44, -6.41]), PPBG (WMD: -14.79 mg/dl, 95% CI [-24.19, -5.39]), and HbA1c (WMD: -0.57%, 95% CI [-0.77, -0.37]). Subgroup analysis revealed that N. sativa oil was more effective than N. sativa powder in reduction of FPG. To sum up, N. sativa consumption has a significant lowering effect on glycemic status. Further studies with prolonged durations and powerful design are needed to specify the exact mechanism, optimal dosage, and duration of N. sativa supplementation to obtain a beneficial effect on glycemic status.

Keywords: Nigella sativa; fasting blood sugar; glycemic control; meta-analysis.

Publication types

  • Meta-Analysis
  • Systematic Review

MeSH terms

  • Blood Glucose / drug effects*
  • Humans
  • Hypoglycemic Agents / pharmacology
  • Hypoglycemic Agents / therapeutic use*
  • Nigella sativa / chemistry*
  • Seeds / chemistry*

Substances

  • Blood Glucose
  • Hypoglycemic Agents